| Product Code: ETC6140506 | Publication Date: Sep 2024 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Argentina large molecule drug substance CDMO market witnessed a steady increase in imports during 2020-2024. The compound annual growth rate (CAGR) for the period was 6.57%. Notably, the year-on-year growth rate spiked to 12.28% in 2023-2024, indicating a significant surge in imported large molecule drug substances during that period.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Argentina Large Molecule Drug Substance CDMO Market Overview |
3.1 Argentina Country Macro Economic Indicators |
3.2 Argentina Large Molecule Drug Substance CDMO Market Revenues & Volume, 2022 & 2032F |
3.3 Argentina Large Molecule Drug Substance CDMO Market - Industry Life Cycle |
3.4 Argentina Large Molecule Drug Substance CDMO Market - Porter's Five Forces |
3.5 Argentina Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By Service, 2022 & 2032F |
3.6 Argentina Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By Source, 2022 & 2032F |
3.7 Argentina Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By End-user, 2022 & 2032F |
4 Argentina Large Molecule Drug Substance CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for large molecule drug development outsourcing services in Argentina |
4.2.2 Growing investments in biopharmaceutical research and development in the region |
4.2.3 Favorable government policies supporting the pharmaceutical and biotech industry in Argentina |
4.3 Market Restraints |
4.3.1 Regulatory challenges and compliance requirements in the large molecule drug substance CDMO market in Argentina |
4.3.2 Lack of skilled workforce and expertise in large molecule drug manufacturing |
4.3.3 Pricing pressures and competition from established global CDMOs |
5 Argentina Large Molecule Drug Substance CDMO Market Trends |
6 Argentina Large Molecule Drug Substance CDMO Market, By Types |
6.1 Argentina Large Molecule Drug Substance CDMO Market, By Service |
6.1.1 Overview and Analysis |
6.1.2 Argentina Large Molecule Drug Substance CDMO Market Revenues & Volume, By Service, 2022-2032F |
6.1.3 Argentina Large Molecule Drug Substance CDMO Market Revenues & Volume, By Contract Manufacturing, 2022-2032F |
6.1.4 Argentina Large Molecule Drug Substance CDMO Market Revenues & Volume, By Clinical, 2022-2032F |
6.1.5 Argentina Large Molecule Drug Substance CDMO Market Revenues & Volume, By Commercial, 2022-2032F |
6.1.6 Argentina Large Molecule Drug Substance CDMO Market Revenues & Volume, By Contract Development, 2022-2032F |
6.1.7 Argentina Large Molecule Drug Substance CDMO Market Revenues & Volume, By Cell Line Development, 2022-2032F |
6.1.8 Argentina Large Molecule Drug Substance CDMO Market Revenues & Volume, By Process Development, 2022-2032F |
6.2 Argentina Large Molecule Drug Substance CDMO Market, By Source |
6.2.1 Overview and Analysis |
6.2.2 Argentina Large Molecule Drug Substance CDMO Market Revenues & Volume, By Mammalian, 2022-2032F |
6.2.3 Argentina Large Molecule Drug Substance CDMO Market Revenues & Volume, By Microbial, 2022-2032F |
6.2.4 Argentina Large Molecule Drug Substance CDMO Market Revenues & Volume, By Others, 2022-2032F |
6.3 Argentina Large Molecule Drug Substance CDMO Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 Argentina Large Molecule Drug Substance CDMO Market Revenues & Volume, By Biotech Companies, 2022-2032F |
6.3.3 Argentina Large Molecule Drug Substance CDMO Market Revenues & Volume, By CRO, 2022-2032F |
6.3.4 Argentina Large Molecule Drug Substance CDMO Market Revenues & Volume, By Others, 2022-2032F |
7 Argentina Large Molecule Drug Substance CDMO Market Import-Export Trade Statistics |
7.1 Argentina Large Molecule Drug Substance CDMO Market Export to Major Countries |
7.2 Argentina Large Molecule Drug Substance CDMO Market Imports from Major Countries |
8 Argentina Large Molecule Drug Substance CDMO Market Key Performance Indicators |
8.1 Number of new partnerships and collaborations between local players and global pharmaceutical companies |
8.2 Investment trends in infrastructure and technology upgrades within the large molecule drug substance CDMO sector in Argentina |
8.3 Percentage increase in the number of clinical trials conducted using drug substances manufactured by local CDMOs |
9 Argentina Large Molecule Drug Substance CDMO Market - Opportunity Assessment |
9.1 Argentina Large Molecule Drug Substance CDMO Market Opportunity Assessment, By Service, 2022 & 2032F |
9.2 Argentina Large Molecule Drug Substance CDMO Market Opportunity Assessment, By Source, 2022 & 2032F |
9.3 Argentina Large Molecule Drug Substance CDMO Market Opportunity Assessment, By End-user, 2022 & 2032F |
10 Argentina Large Molecule Drug Substance CDMO Market - Competitive Landscape |
10.1 Argentina Large Molecule Drug Substance CDMO Market Revenue Share, By Companies, 2025 |
10.2 Argentina Large Molecule Drug Substance CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here